ArticleInternational journal of rheumatic diseases2026
JAK Inhibitor Tofacitinib Ameliorates Inflammation Response and Osteogenic Differentiation in Immune-Mediated Inflammatory Arthritis in Rats.
Zhiming Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.